Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/30/2025

Hydrocortisone Weaning in Infants with Bronchopulmonary Dysplasia

Tapering Protocol

  • A typical regimen uses 0.5 mg/kg of hydrocortisone every 12 hours, then tapers to 0.25 mg/kg every 12 hours for the final three days before discontinuation【1】.
  • Most studies employed a 10–12 day treatment course followed by a 3‑day taper, which appears to be the minimum effective duration before initiating weaning【2】.

Monitoring During the Wean

  • Respiratory status – clinicians should watch for increased oxygen requirements, heightened work of breathing, or need for escalated ventilatory support, which may signal premature weaning【3】.
  • Adrenal function – signs of adrenal insufficiency (e.g., hypotension, hypoglycemia, hyponatremia, hyperkalemia) are more likely when hydrocortisone has been administered for more than 7–10 days【4】.
  • Blood pressure and glucose – regular blood‑pressure checks are advised because hypertension can persist or worsen during tapering【4】.

Rationale for Gradual Withdrawal

  • Prolonged corticosteroid exposure can suppress the hypothalamic‑pituitary‑adrenal (HPA) axis, necessitating a gradual taper to allow axis recovery【3】.
  • Abrupt discontinuation may trigger rebound pulmonary inflammation, leading to respiratory deterioration in infants with BPD【3】.
  • Hydrocortisone has shown a more favorable neurodevelopmental safety profile than dexamethasone, with no adverse effects on outcomes at 18–22 months【1】.

Clinical Decision Points

  • If respiratory status worsens during taper, the taper rate should be slowed or the dose temporarily increased to the prior level before attempting a slower reduction【3】.
  • Appearance of adrenal insufficiency warrants stress‑dose hydrocortisone (2–3 × maintenance) during acute illness or procedures and an extension of the taper duration【4】.
  • Initiating hydrocortisone within the first two weeks of life for BPD prevention is best paired with the standard 10–12 day course and 3‑day taper; later “rescue” therapy after three weeks typically starts at 1 mg/kg twice daily with tapering by 10–20 % every other day based on clinical response【2】.

Safety Considerations with Concomitant Medications

  • Infants receiving indomethacin or ibuprofen for patent ductus arteriosus closure have an increased risk of gastrointestinal perforation when combined with early hydrocortisone, although this risk is lower than with dexamethasone【5】.